SCHEMBL8199636

SCHEMBL8199636

Cc1ccc(S(=O)(=O)N(CCN(CC(=O)Cl)S(=O)(=O)c2ccc(C)cc2)CCN(CC(=O)Cl)S(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 2/20 0.49
NFE2L2 Q16236 2/20 0.49
GLA P06280 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.48
CA12 O43570 3/20 0.46
CA9 Q16790 3/20 0.46
CA2 P00918 2/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
SLC22A8 Q8TCC7 1/20 0.46
ABCC2 Q92887 1/20 0.46
SLC22A12 Q96S37 1/20 0.46
UGT1A7 Q9HAW7 1/20 0.46
SLC22A11 Q9NSA0 1/20 0.46
TAS2R14 Q9NYV8 2/20 0.46
CNR2 P34972 2/20 0.46
ALDH1A1 P00352 2/20 0.44
CA1 P00915 2/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11554636 0.98 KEAP1 (0.50) KEAP1NFE2L2GLAL3MBTL1CA12
SCHEMBL8200276 0.85 KEAP1 (0.62) KEAP1NFE2L2GLAL3MBTL1CA12
SCHEMBL8607609 0.83 KEAP1 (0.64) KEAP1NFE2L2GLAL3MBTL1CA12
SCHEMBL15177296 0.80 SMN1; SMN2 (0.66) KEAP1NFE2L2GLAL3MBTL1CA12
SCHEMBL8192690 0.80 SMN1; SMN2 (0.66) KEAP1NFE2L2GLAL3MBTL1CA12
SCHEMBL11550968 0.79 TSHR (0.52) KEAP1NFE2L2GLAL3MBTL1SMN1; SMN2
SCHEMBL11796193 0.79 KEAP1 (0.54) KEAP1NFE2L2GLACA12CA9
SCHEMBL25220429 0.79 TAS2R14 (0.54) TAS2R14CNR2ALDH1A1MEN1KMT2A
SCHEMBL398044 0.78 CNR2 (0.57) GLARAB9ASMN1; SMN2CNR2LMNA
SCHEMBL218536 0.78 SMN1; SMN2 (0.68) KEAP1NFE2L2GLAL3MBTL1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6084093-A SUBSTITUTED 1,4,7,10,13-PENTAAZACYCLOPENTADECANE MACROCYCLIC LIGANDS; MANGANESE COMPLEXES OF THE LIGAND ARE MIMICS OF SUPEROXIDE DISMUTASE; USEFUL AS THERAPEUTIC AGENTS FOR INFLAMMATORY DISEASES G. D. SEARLE & CO. (US) 2000-07-04 US disclosed
US-5874421-A Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide G. D. SEARLE & CO. (US) 1999-02-23 US disclosed
EP-0598753-B1 MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO CO (US) 1998-03-18 EP disclosed
US-5637578-A AGENTS FOR INFLAMMATION, ISCHEMIC/REPERFUSION INJURY, STROKE, ATHEROSCLEROSIS, AND HYPERTENSION MONSANTO COMPANY 1997-06-10 US disclosed
US-5610293-A TREATMENT OF INFLAMMATORY DISEASES, ISCHEMIC/REPERFUSION INJURY, STROKE, ATHERSCLEROSIS, HYPERTENSION MONSANTO COMPANY (US) 1997-03-11 US disclosed
EP-0756495-A1 DIAGNOSTIC IMAGE ANALYSIS WITH METAL COMPLEXES MONSANTO COMPANY (US) 1997-02-05 EP disclosed
WO-1995028968-A1 DIAGNOSTIC IMAGE ANALYSIS WITH METAL COMPLEXES MONSANTO COMPANY (US) 1995-11-02 WO disclosed
EP-0598753-A1 MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO COMPANY (US) 1994-06-01 EP disclosed
WO-1993002090-A1 MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO COMPANY (US) 1993-02-04 WO disclosed
EP-0524161-A1 Manganese complexes of nitrogen containing macrocyclic ligands effective as catalysts for dismutating superoxide MONSANTO COMPANY (US) 1993-01-20 EP disclosed